首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1458024

全球生物标记市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球生物标记市场需求预计将从 2023 年的 578 亿美元增至 2032 年的近 1,480.9 亿美元，2024-2032 年研究期间复合CAGR为 11.02%。

生物标记是可以在生物样本中检测到的可测量的指示剂或物质，并提供有关各种生理或病理过程的资讯。生物标记广泛应用于医学研究和诊断，可以指示疾病的存在、进展或对治疗的反应。例子包括血液或组织中的蛋白质、基因或特定分子。生物标记在个人化医疗中发挥着至关重要的作用，有助于识别高风险个体、早期疾病检测和监测治疗效果。

市场动态

生物标记在疾病诊断、预后和监测治疗反应中发挥着至关重要的作用，有助于个人化医疗方法。癌症和心血管疾病等慢性疾病负担的激增推动了市场的成长。基因组学、蛋白质组学和代谢组学技术的进步有助于识别新型生物标记物，扩大其应用范围。早期疾病检测、及时介入、改善患者治疗结果以及对精准医疗和标靶治疗的日益重视进一步推动市场成长。对生物标记验证和批准流程的监管支持增强了其与临床实践的融合。对各种疾病的研发投资不断增加，促进了市场的持续成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球生物标记市场的每个细分市场进行了包容性评估。生物标记物产业的成长和趋势为这项研究提供了整体方法。

市场区隔

生物标誌物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品和服务

耗材
服务
装置

按类型

安全生物标记
易感性/风险生物标誌物
诊断生物标记
预后生物标记
监测生物标记
预测性生物标记
药效/反应生物标记

按申请

诊断
药物发现与开发
个人化医疗
疾病风险评估
其他的

按疾病适应症

癌症
神经系统疾病
心血管疾病
传染性疾病
免疫系统疾病
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲生物标记物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

按地区分類的全球生物标记市场份额（代表性图）
全球生物标誌物市场份额

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物标记市场的主要参与者包括 Abbott Laboratories、Agilent Technology、Becton、Dickinson and Company、Bio-Rad Laboratories、BioMerieux SA (Astute Medical)、Merck KGaA、Qiagen NV、Quanterix、Quest Diagnostics、Thermo Fisher Scientific Inc。包括 Fisher Scientific Inc。包括对竞争格局的整体看法，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按产品和服务分類的市场吸引力分析
- 按类型分類的市场吸引力分析
- 市场吸引力分析：依应用分类
- 依疾病适应症进行的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球生物标记市场分析：按产品和服务分类

按产品和服务分類的概述
历史和预测数据
按产品和服务分析
耗材
服务
装置

第 6 章：全球生物标记市场分析：按类型

按类型概述
历史和预测数据
按类型分析
安全生物标记
易感性/风险生物标誌物
诊断生物标记
预后生物标记
监测生物标记
预测性生物标记
药效/反应生物标记

第 7 章：全球生物标记市场分析：按应用分类

概述：按应用
历史和预测数据
分析：按应用
诊断
药物发现与开发
个人化医疗
疾病风险评估
其他的

第 8 章：全球生物标记市场分析：按疾病适应症

按疾病适应症概述
历史和预测数据
按疾病指征分析
癌症
神经系统疾病
心血管疾病
传染性疾病
免疫系统疾病
其他的

第 9 章：全球生物标记市场分析：按地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：生物标记物公司的竞争格局

生物标记市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

公司股份分析
市场集中度
Abbott Laboratories

公司简介
公司收入
产品
最近的发展

Agilent Technology

公司简介
公司收入
产品
最近的发展

Becton

公司简介
公司收入
产品
最近的发展

Dickinson and Company

公司简介
公司收入
产品
最近的发展

Bio-Rad Laboratories

公司简介
公司收入
产品
最近的发展

BioMerieux SA (Astute Medical)

公司简介
公司收入
产品
最近的发展

Merck KGaA

公司简介
公司收入
产品
最近的发展

Qiagen NV

公司简介
公司收入
产品
最近的发展

Quanterix

公司简介
公司收入
产品
最近的发展

Quest Diagnostics

公司简介
公司收入
产品
最近的发展

Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113891

The global demand for Biomarkers Market is presumed to reach the market size of nearly USD 148.09 BN by 2032 from USD 57.80 BN in 2023 with a CAGR of 11.02% under the study period 2024 - 2032.

Biomarkers are measurable indicators or substances that can be detected in biological samples and provide information about various physiological or pathological processes. Widely used in medical research and diagnostics, biomarkers can indicate the presence, progression, or response to treatment of diseases. Examples include proteins, genes, or specific molecules in blood or tissue. Biomarkers play a vital role in personalized medicine, aiding in identifying at-risk individuals, early disease detection, and monitoring treatment efficacy.

MARKET DYNAMICS

Biomarkers play a vital role in disease diagnosis, prognosis, and monitoring treatment responses, contributing to personalized medicine approaches. The surging burden of chronic diseases, such as cancer and cardiovascular disorders, fuels the market growth. Advances in genomics, proteomics, and metabolomics technologies contribute to identifying novel biomarkers, expanding the scope of their applications. Early disease detection, enabling timely interventions, improved patient outcomes, and growing emphasis on precision medicine and targeted therapies further propel market growth. Regulatory support for biomarker validation and approval processes enhances their integration into clinical practice. The rising investments in research and development for various diseases contribute to the market's continuous growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biomarkers. The growth and trends of biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Consumables
Services
Equipment

By Type

Safety Biomarkers
Susceptibility/Risk Biomarkers
Diagnostic Biomarkers
Prognostic Biomarkers
Monitoring Biomarkers
Predictive Biomarkers
Pharmacodynamic/Response Biomarkers

By Application

Diagnostics
Drug Discovery & Development
Personalized Medicine
Disease Risk Assessment
Others

By Disease Indication

Cancer
Neurological Disorders
Cardiovascular Disorders
Infectious Diseases
Immune Disorders
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL BIOMARKERS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global Biomarkers Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biomarkers market include Abbott Laboratories, Agilent Technology, Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux SA (Astute Medical), Merck KGaA, Qiagen NV, Quanterix, Quest Diagnostics, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BIOMARKERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Disease Indication
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BIOMARKERS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1 Overview by Product & Service
5.2 Historical and Forecast Data
5.3 Analysis by Product & Service
5.4 Consumables Historic and Forecast Sales by Regions
5.5 Services Historic and Forecast Sales by Regions
5.6 Equipment Historic and Forecast Sales by Regions

6 . GLOBAL BIOMARKERS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Safety Biomarkers Historic and Forecast Sales by Regions
6.5 Susceptibility/Risk Biomarkers Historic and Forecast Sales by Regions
6.6 Diagnostic Biomarkers Historic and Forecast Sales by Regions
6.7 Prognostic Biomarkers Historic and Forecast Sales by Regions
6.8 Monitoring Biomarkers Historic and Forecast Sales by Regions
6.9 Predictive Biomarkers Historic and Forecast Sales by Regions
6.10. Pharmacodynamic/Response Biomarkers Historic and Forecast Sales by Regions

7 . GLOBAL BIOMARKERS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Diagnostics Historic and Forecast Sales by Regions
7.5 Drug Discovery & Development Historic and Forecast Sales by Regions
7.6 Personalized Medicine Historic and Forecast Sales by Regions
7.7 Disease Risk Assessment Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL BIOMARKERS MARKET ANALYSIS BY DISEASE INDICATION

8.1 Overview by Disease Indication
8.2 Historical and Forecast Data
8.3 Analysis by Disease Indication
8.4 Cancer Historic and Forecast Sales by Regions
8.5 Neurological Disorders Historic and Forecast Sales by Regions
8.6 Cardiovascular Disorders Historic and Forecast Sales by Regions
8.7 Infectious Diseases Historic and Forecast Sales by Regions
8.8 Immune Disorders Historic and Forecast Sales by Regions
8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE BIOMARKERS COMPANIES

10.1. Biomarkers Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF BIOMARKERS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Abbott Laboratories
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Agilent Technology
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Becton
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Dickinson and Company
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Bio-Rad Laboratories
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. BioMerieux SA (Astute Medical)
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Merck KGaA
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Qiagen NV
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Quanterix
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Quest Diagnostics
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Thermo Fisher Scientific Inc.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments